Form D · Biotechnology
EXICURE, INC.
Skokie, IL · CIK 0001698530
Offering snapshot reported Aug 31, 2018 · SEC filing
- Reported sold
- $22M Offering amount: $22M
- Investors reported
- 39 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 22, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2018 | Initial | $22,001,477 | No comparison | 39 | SEC filing |
| Oct 10, 2017 | Initial | $43,090,544 | No comparison | 84 | SEC filing |
| Oct 10, 2017 | Initial | $20,791,609 | No comparison | 119 | SEC filing |
| Jul 3, 2017 | Initial | $6,250 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.77M
- Finders' fees
- $0
- Form D file number
- 021-320477
Includes expenses incurred in connection with the closing of the private placement financing.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Katalyst Securities LLC | 112494 | |
| Ladenburg Thalmann & Co. Inc. | 505 | |
| Castle Hill Capital Partners, Inc. | 44131 |
Source: Form D, filed Aug 31, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David A. Giljohann | Director, Executive |
| Ian Jacobs | Director, Executive |
| Ekambar Kandimalla | Executive |
| Helen S. Kim | Director |
| Chad Mirkin | Director |
| Matthias Schroff | Executive |
| David S. Snyder | Executive |
| C. Shad Thaxton | Director |
| Mark Tompkins | Director |
| Jay R. Venkatesan | Director |
| David R. Walt | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8045 Lamon Ave, Suite 410
Skokie, IL, 60077
Skokie, IL, 60077